Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC

home / uroview / deep-data-dive-highlights-from-asco-2024-on-the-treatment-of-high-risk-bcg-unresponsive-nmibc

Trinity Bivalacqua, MD, PhD, addresses updates in high-risk BCG-unresponsive NMIBC treatment presented at ASCO 2024.

EP. 1: UPCOMING SERIES: Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC

June 26th 2024

Trinity Bivalacqua, MD, PhD, announces an upcoming UroView series highlighting key information presented at ASCO 2024 surrounding treatment of high-risk BCG-unresponsive NMIBC.

Recent Content

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

SBRT may offer a safe alternative to CFRT after prostatectomy

Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

Blurred interior of hospital - abstract medical background. | Image Credit: © jakkapan - stock.adobe.com

Real-time IRP monitoring may redefine safety and scope of flexible ureteroscopy

View More Recent Content

Do not sell my Personnal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777